SU345815A1 - - Google Patents

Info

Publication number
SU345815A1
SU345815A1 SU1656803A SU1656803A SU345815A1 SU 345815 A1 SU345815 A1 SU 345815A1 SU 1656803 A SU1656803 A SU 1656803A SU 1656803 A SU1656803 A SU 1656803A SU 345815 A1 SU345815 A1 SU 345815A1
Authority
SU
USSR - Soviet Union
Prior art keywords
pll
glucoamylase
iio
dia
exchange
Prior art date
Application number
SU1656803A
Other languages
English (en)
Russian (ru)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to SU1656803A priority Critical patent/SU345815A1/ru
Priority to CH470972A priority patent/CH583777A5/xx
Priority to DE19722226354 priority patent/DE2226354A1/de
Application granted granted Critical
Publication of SU345815A1 publication Critical patent/SU345815A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C12N9/2414—Alpha-amylase (3.2.1.1.)
    • C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
    • C12N9/242—Fungal source
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C12N9/2428—Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Detergent Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SU1656803A 1971-05-31 1971-05-31 SU345815A1 (enExample)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SU1656803A SU345815A1 (enExample) 1971-05-31 1971-05-31
CH470972A CH583777A5 (enExample) 1971-05-31 1972-03-29
DE19722226354 DE2226354A1 (de) 1971-05-31 1972-05-30 Verfahren zur herstellung von amylolytischen fermenten wie glukoamylase, alphaamylase und transglukosilase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU1656803A SU345815A1 (enExample) 1971-05-31 1971-05-31

Publications (1)

Publication Number Publication Date
SU345815A1 true SU345815A1 (enExample) 1973-10-19

Family

ID=20475287

Family Applications (1)

Application Number Title Priority Date Filing Date
SU1656803A SU345815A1 (enExample) 1971-05-31 1971-05-31

Country Status (3)

Country Link
CH (1) CH583777A5 (enExample)
DE (1) DE2226354A1 (enExample)
SU (1) SU345815A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK438283D0 (da) * 1983-09-26 1983-09-26 Novo Industri As Syrestabilt alpha-amylaseenzymprodukt og fremstilling deraf
US4689296A (en) * 1985-09-23 1987-08-25 Miles Laboratories, Inc. Method of preparing novel thermostable transglucosidase

Also Published As

Publication number Publication date
DE2226354A1 (de) 1973-01-11
CH583777A5 (enExample) 1977-01-14

Similar Documents

Publication Publication Date Title
Jouaville et al. Synchronization of calcium waves by mitochondrial substrates in Xenopus laevis oocytes
Weber et al. Immunohistochemical distribution of dynorphin B in rat brain: relation to dynorphin A and alpha-neo-endorphin systems.
Finlayson et al. Stone matrix and mucoprotein from urine
JPS58135818A (ja) 貯蔵寿命の長い高酸素輸送能力を有する交叉結合されたヘモグロビン剤の製法
SU345815A1 (enExample)
Charm et al. Shear degradation of fibrinogen in the circulation
ATE16567T1 (de) Intravenoes injektierbares globulin aus immunserum und verfahren zu seiner herstellung.
DK0660705T3 (da) Avanceret lægemiddelafgivelsessystem og fremgangsmåde til behandling af psykiatriske, neurologiske og andre lidelser med ca
US3607858A (en) Process for preparing lyophilized human blood proteins such as gamma globulin in the presence of a nonionic surfactant
Brinckerhoff et al. Survival of rheumatoid synovium implanted into nude mice
DK304288D0 (da) Fremgangsmaade til fremstilling af en oploesning med hoej specifik rumgangsaktivitet af et protein med vaevs-plasmino-genaktivator (t-pa)-aktivitet og anvendelse af en oploesning, der indeholder protein med t-pa-aktivitet
Markley et al. Utilization of polyelectrolyte complexes in biology and medicine
DE69919684T2 (de) Verwendung von isolierten domänen des type-iv-kollagens zur änderung der zell- und gewebewechselwirkung
Emmett et al. Thermal uncoupling in chloroplasts. Inhibition of photophosphorylation without depression of light-induced pH change
GB1297080A (enExample)
FR2345165A1 (fr) Rein artificiel : controle volumetrique de l'ultrafiltration
ES420846A1 (es) Metodo de preparacion de un concentrado de globulina gamma altamente soluble.
Vivien et al. Rabbit articular chondrocytes (RAC) express distinct transforming growth factor-β receptor phenotypes as a function of cell cycle phases
WOOD et al. THE EFFECT OF TIMING OF SKIN GRAFTS ON SUBSEQUENT SURVIVAL IN ALS-TREATED, MARROW-INFUSED MICE1
Cioli et al. Catabolic origin of a Bence Jones protein fragment
Larsson et al. Light microscopic and ultrastructural observations on the short‐term effects of ethylene‐1‐hydroxy‐1, 1‐diphosphonate (EHDP) on rat tibia epiphysis
Terada et al. Hemorrhagic infarction after vasospasm due to ruptured cerebral aneurysm
Okuda Enhanced vitamin B12 absorption from rat intestine by proteases in the absence of intrinsic factor
Ford et al. The effect of Arvin on experimental immune arthritis in rabbits
KR102025546B1 (ko) 히알루론산-칼슘 복합체 및 알지네이트를 포함하는 약물 전달체